Akcea Therapeutics, Inc. (AKCA)


Akcea Therapeutics, Inc. (AKCA)

$21.67 USD

0.67 (-3.00%)

Updated Jul 17 11:12am

Add AKCA to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 322 in Biotech

See all “A” rated Strong Buy stocks

AKCA Daily Price Range
AKCA 52-Week Price Range

AKCA News Stream

Event/Time News Detail Start End Change
Loading, please wait...
View All AKCA News

Akcea Therapeutics, Inc. (AKCA) Company Bio


Akcea Therapeutics Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing drugs to treat patients with cardiometabolic diseases caused by lipid disorders in the United States and internationally. The company was founded in 2014 and is based in Cambridge, Massachusetts.

AKCA Stock Chart More Charts


AKCA Price/Volume Stats

Current price $21.67
Prev. close $22.34
Day low $21.63
Day high $22.43
50-day MA $22.58
200-day MA $27.06
52-week high $40.75
52-week low $19.67
Volume 63,790
Avg. volume 223,229
Dividend yield N/A
Market Cap 2.01B

AKCA Social Stream


Loading social stream, please wait...

View Full AKCA Social Stream

AKCA Returns

1-mo -11.15%
3-mo -19.74%
6-mo -27.91%
1-year -22.47%
3-year N/A
5-year N/A
YTD -28.10%
2018 73.62%
2017 N/A
2016 N/A
2015 N/A
2014 N/A


Page generated in 0.4408 seconds.